PURLs

Think Twice About Nebulizers for Asthma Attacks

MDIs with spacers are as effective as nebulizers for delivering β-agonists and less likely to cause adverse effects.

Author and Disclosure Information

 

PRACTICE CHANGER
Stop ordering nebulizers to deliver β-agonists to patients older than 2 who have mild or moderate asthma exacerbations. A metered-dose inhaler (MDI) with a spacer produces the same benefits with fewer adverse effects.1

STRENGTH OF RECOMMENDATION
A: Based on an updated Cochrane meta-analysis of 39 randomized controlled trials (RCTs). 1

ILLUSTRATIVE CASE
A 6-year-old girl with a history of reactive airway disease comes to your office complaining of cough and wheezing. On exam, she has mild retractions, a respiratory rate of 35 breaths/min, and an O2 saturation of 96% on room air. Her lung fields are diffusely wheezy. Her parents would like to keep her out of the hospital. How should you order her albuterol to decrease her wheezing and minimize adverse effects?

Pages

Recommended Reading

Do Antibiotics Contribute to Pediatric C difficile Infection Rate?
Clinician Reviews
Asthma May Increase Risk of Cardiovascular Events
Clinician Reviews
Allergic Rhinitis & Immunotherapy: Hope or Hype
Clinician Reviews
FDA Approves First Grass-pollen Allergy Pill
Clinician Reviews
Minority Correctly Use EpiPen or Metered Dose Inhaler
Clinician Reviews
Aspirin Sensitivity Signals Asthma Severity
Clinician Reviews
FDA Approves Three Sublingual Allergy Meds in a Month
Clinician Reviews
No Relief From Persistent Itchy Rash
Clinician Reviews
Peanut Reactivity After Immunotherapy
Clinician Reviews
Tips for Vaccinating Multiple Sclerosis Patients
Clinician Reviews

Related Articles